Company Filing History:
Years Active: 2009
Title: Emmanuel Riguet: Innovator in Peptide Nucleic Acid Conjugates
Introduction
Emmanuel Riguet is a notable inventor based in Saint Thomas en Royans, France. He has made significant contributions to the field of biotechnology, particularly in the development of peptide nucleic acid (PNA) conjugates. His work focuses on innovative methods and compositions that have the potential to impact medical treatments.
Latest Patents
Riguet holds a patent for "PNA-neamine conjugates and methods for producing and using the same." This invention relates to conjugates composed of a peptide nucleic acid moiety and a neamine derivative moiety. The patent outlines methods for using these conjugates to modulate the activity of target nucleic acid molecules. Additionally, it provides approaches for preventing or treating diseases associated with aberrant nucleic acid molecules. Riguet has 1 patent to his name.
Career Highlights
Emmanuel Riguet is affiliated with the University of Medicine and Dentistry of New Jersey, where he has contributed to research and development in his field. His academic background and research endeavors have positioned him as a key figure in the study of nucleic acid technologies.
Collaborations
Riguet has collaborated with esteemed colleagues such as Jean-Luc Decout and Virendra N Pandey. These partnerships have enhanced his research capabilities and broadened the impact of his inventions.
Conclusion
Emmanuel Riguet's innovative work in peptide nucleic acid conjugates showcases his commitment to advancing biotechnology. His contributions have the potential to lead to significant medical advancements in the treatment of diseases related to nucleic acids.